These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 961802)

  • 1. Plasma cortisol suppression test used to predict the development of primary open-angle glaucoma.
    Kass MA; Krupin T; Becker B
    Am J Ophthalmol; 1976 Sep; 82(3):496-7. PubMed ID: 961802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.
    Lewis JM; Priddy T; Judd J; Gordon MO; Kass MA; Kolker AE; Becker B
    Am J Ophthalmol; 1988 Nov; 106(5):607-12. PubMed ID: 3189477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diphenylhydantoin on dexamethasone suppression of plasma cortisol in primary open-angle glaucoma.
    Krupin T; Podos SM; Becker B
    Am J Ophthalmol; 1971 May; 71(5):997-1002. PubMed ID: 5562526
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of plasma cortisol in normal and glaucomatous patients.
    Rosenberg S; Levene R
    Arch Ophthalmol; 1974 Jul; 92(1):6-9. PubMed ID: 4835969
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma cortisol differences between normal and glaucomatous patients: before and after dexamethasone suppresion.
    Schwartz B; Levene RZ
    Arch Ophthalmol; 1972 Apr; 87(4):369-77. PubMed ID: 5018239
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma cortisol in glaucoma.
    Ray S; Mehra KS; Misra S; Singh R
    Ann Ophthalmol; 1977 Sep; 9(9):1151-4. PubMed ID: 561563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenylhydantoin and dexamethasone-induced changes of plasma cortisol: comparison of patients with and without glaucoma.
    Becker B; Krupin T; Podos SM
    J Clin Endocrinol Metab; 1971 May; 32(5):669-70. PubMed ID: 5577886
    [No Abstract]   [Full Text] [Related]  

  • 8. [The 8-year follow-up study for clinical diagnostic potentials of frequency-doubling technology perimetry for perimetrically normal eyes of open-angle glaucoma patients with unilateral visual field loss].
    Fan X; Wu LL; Xiao GG; Ma ZZ; Liu F
    Zhonghua Yan Ke Za Zhi; 2018 Mar; 54(3):177-183. PubMed ID: 29518875
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma cortisol suppression in glaucoma.
    Becker B; Podos SM; Asseff CF; Cooper DG
    Am J Ophthalmol; 1973 Jan; 75(1):73-6. PubMed ID: 4684267
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic value of HLA-B12 and HLA-B7 antigens in patients with increased intraocular pressure.
    Shin DH; Becker B
    Am J Ophthalmol; 1976 Dec; 82(6):871-4. PubMed ID: 998703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma.
    Mao LK; Stewart WC; Shields MB
    Am J Ophthalmol; 1991 Jan; 111(1):51-5. PubMed ID: 1985490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma free cortisol in ocular hypertension and open angle glaucoma.
    Schwartz B; McCarty G; Rosner B
    Arch Ophthalmol; 1987 Aug; 105(8):1060-5. PubMed ID: 2888454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma.
    Stokes J; Walker BR; Campbell JC; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5163-7. PubMed ID: 14638712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hydrocortisone (cortisol) values in glaucomatous and normotensive Beagles.
    Chen CL; Gelatt KN; Gum GG
    Am J Vet Res; 1980 Sep; 41(9):1516-8. PubMed ID: 7192525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function and the intraocular pressure response to topical corticosteroids.
    Krupin T; Jacobs LS; Podos SM; Becker B
    Am J Ophthalmol; 1977 May; 83(5):643-6. PubMed ID: 868963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylhydantoin and cortisol metabolism in glaucoma.
    Podos SM; Becker B; Beaty C; Cooper DG
    Am J Ophthalmol; 1972 Sep; 74(3):498-500. PubMed ID: 5053695
    [No Abstract]   [Full Text] [Related]  

  • 18. The reproducibility of the intraocular pressure response to dexamethasone.
    Palmberg PF; Mandell A; Wilensky JT; Podos SM; Becker B
    Am J Ophthalmol; 1975 Nov; 80(5):844-56. PubMed ID: 1190278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cortisol suppression response in the South African black population with glaucoma.
    Freedman J; David R; van der Walt LA; Luntz MH
    Br J Ophthalmol; 1976 Nov; 60(11):786-8. PubMed ID: 1009059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.